Pharmacodynamics of antimalarial chemoprevention

Ended Project Grant Awarded Last action

Award ID
R01AI117001
Recipient
Awarding agency
Obligated
$7,137,889

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Originally
Place of performance
San Francisco, CA 94110, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment $756,520
Amendment $747,650
Amendment $731,681
Amendment -$339,383
Amendment $339,383
Amendment $727,306
Amendment $759,552
Amendment $0
Amendment Pharmacological insights into antimalarial exposure, clinical outcomes, and drug resistance in africa $670,155
Amendment $681,596
Amendment $681,596
Amendment $681,596
Original award $700,237
Show all 14

Subawards

Subrecipient Amount Awarded
Infectious Diseases Research Collaboration Project Description: Pharmacological insights into antimalarial exposure, clinical outcomes, and drug resistance in Africa This project, which began very… $83,572
Institut De Recherche En Sciences De La Sante We will assess the ex vivo susceptibilities of fresh Plasmodium falciparum isolates to candidate antimalarial compounds supplied by the Medicines for Malaria… $308,642
Infectious Diseases Research Collaboration Continuation, No Change $30,000

Quick answers

Who received award R01AI117001?

R01AI117001 was awarded to The Regents Of The University Of California. San Francisco by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on February 11, 2015.

How much is award R01AI117001 worth?

$7,137,889 has been obligated on R01AI117001.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award